Evidence Generation: Evolution and Future of Integrated Evidence Planning

    Session Details

    Integrated evidence planning (IEP) offers a comprehensive framework that harnesses various data sources, scientific methodologies, and cross-functional expertise throughout a product's life cycle, effectively delivering crucial insights into its benefits, safety, and value. Our webinar delved into the functional and operational dimensions of IEP, elucidating its rationale and myriad benefits. The panelists explored the journey of IEP and provided valuable insights into potential barriers associated with IEP and strategies to surmount them. Additionally, they explained operational aspects, including the development, implementation, and optimization of IEP systems.

    In this webinar, industry leaders Chris Blanchette, Ph.D. from Novo Nordisk and Shibani Pokras from GSK along with Axtria‘s Principal and HEOR/RWE Practice lead, Won Chan Lee, Ph.D. discussed:

    • The evolutionary journey of IEP.
    • Challenges related to IEP and their potential solutions.
    • Architecture of IEP, processes involved in their development, implementation, and operation.
    • Insights on emerging innovative trends in IEP.

    Book A Meeting With Our Experts


    Won Chen Lee

    Won Chan Lee, Ph.D. , Principal and Practice Lead of HEOR/RWE Practice, Axtria – Ingenious Insights

    Dr. Lee serves as RWE, HEOR & Evidence Synthesis Practice Lead and Principal at Axtria. He has more than 20 years of experience in HEOR, including strategic planning, economic modeling, RWE database studies, post-marketing studies, HRQL/PRO assessments, HEOR roadmap, value proposition development, HTA assessment, and publication strategies. Dr. Lee holds a Ph.D. in Health Economics from the Graduate Center of the City University, New York, and a master's degree in economics from the University of Grenoble, France.

    Chris Blanchette

    Chris Blanchette, Ph.D. , Vice President, Clinical Data Science & Evidence, Novo Nordisk

    Christopher Blanchette is the Vice President of Clinical Data Science and Evidence at Novo Nordisk Inc. With over 20 years of experience, he's a seasoned clinical epidemiologist and health services researcher. Chris holds a PhD/MS in Pharmaceutical Health Services Research and Pharmacoepidemiology from the University of Maryland, an MBA in Pharmaceutical Marketing from Saint Joseph’s University, and has undergone post-graduate training in Clinical Research Management at Duke University.

    Shibani Pokras

    Shibani Pokras, Senior Director and Global Process Owner, Integrated Evidence Planning, GSK

    Shibani Pokras is a seasoned leader with 10 years of experience at GSK and 10 years in health economics and real-world evidence consulting. At GSK, she spearheaded the development of new organizational capabilities as the Global Process Owner of Integrated Evidence Planning. Shibani and her team conducted nearly 50 integrated evidence planning workshops, impacting over 1500 employees globally and winning the prestigious R&D Transformational Medicines & Vaccines Award in 2023 for their contributions.